Bullous pemphigoid in a leg affected with hemiparesia: A possible relation of neurological diseases with bullous pemphigoid?

European Journal of Dermatology

Volumn 11, Issue 3, 2001, Pages 230-233

  Foureur, Nicolas ^a   Descamps, Vincent ^a   Lebrun Vignes, Bébédicte ^a   Picard Dahan, Catherine ^a   Belaich, Maggy ^a   Crickx, Stéphane ^a   Grossin, Béatrice ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Bullous pemphigoid; Bullous pemphigoid antigen 1; Dystonin; Neurological disorder

Indexed keywords

ANTIGEN;

AGED; AGING; ARTICLE; AUTOIMMUNITY; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEMIPARESIS; HEMIPLEGIA; HUMAN; HUMAN TISSUE; NEUROLOGIC DISEASE; PEMPHIGOID; PREVALENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; AUTOANTIGENS; CARRIER PROTEINS; CASE-CONTROL STUDIES; COLLAGEN; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; NON-FIBRILLAR COLLAGENS; PARESIS; PEMPHIGOID, BULLOUS; PREVALENCE; PROGNOSIS; SEQUENCE HOMOLOGY;

EID: 0035013903     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. 1. Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P. High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 1998; 134: 465-9.
2. 2. Long CC, Lever LR, Marks R. Unilateral bullous pemphigoid in a hemiplegic patient. Br J Dermatol 1992; 126: 614-6.
3. 3. Bunker CB. Unilateral bullous pemphigoid in a hemiplegic patient. Br J Dermatol 1993; 129: 502.
4. 4. Tay YK, Cheong WK. An unusual case of localised pemphigoid. Ann Acad of Med Singapore 1993; 22: 937-8.
5. 5. Kirtschig G, Walkden VM, Venning VA, Wojnarowska F. Bullous pemphigoid and multipe sclerosis: a report of three cases and review of the literature. Clin Exp Dermatol 1995; 20: 449-53.
6. 6. Massouye I, Schmied E, Didierjean L, Abba Z, Saurat JH. Bullous pemphigoid and multiple sclerosis: more than a coincidence? J Am Acad Dermatol 1989; 21: 63-8.
7. 7. Tohme A, Mattar L, Zebouni A, Koussa S. Pemphigoide bulleuse et sclérose en plaques. Ann Dermatol Venereol 1994; 121: 139-42.
8. 8. Chosidow O, Doppler V, Bensimon G, Joly P, Salachas F, Lacomblez L, Prost C, Camu W Francès C, Herson S, Meininger V. Bullous pemphigoid and amyotrophic lateral sclerosis. Arch Dermatol 2000; 136: 521-4.
9. 9. Okazaki A. Bullous pemphigoid associated with Shy-Drager syndrome. J Dermatol 1998; 25: 465-8.
10. 10. Brown A, Bernier G, Mathieu M, Rossant J, Kothary R. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet 1995; 10: 301-6.
11. 11.Guo L, Degenstein L, Dowling J, Yu QC, Wolmann R, Perman B, Fuchs E. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 1995; 81: 233-43.
12. 12. Dalpe G, Leclerc N, Vallee A, Messer A, Mathieu M, De Repentigny Y, Kothary R. Dystonin is essential for maintaining neuronal cytoskeleton organization. Mol Cell Neurosci 1998; 10: 243-57.
13. 13. Vaillant L, Bernard P, Joly P, Prost C, Labeille B, Bedane C, Arbeille B, Thomine E, Bertrand P, Lok C, Roujeau JC. Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol 1998; 134: 1075-80.
14. 14. Wick G, Grubeck-Loebenstein B. The aging immune system: primary and secondary alterations of immune reactivity in the elderly. Exp Gerontol 1997; 32: 401-13.
15. 15. Zhou Y, Cheshire A, LHowell LA, Ryan DH, Harris RB. Neuroautoantibody immunoreactivity in relation with aging and stress in apolipoprotein E-deficient mice. Brain Res Bull 1999; 49: 173-9.
16. 16. Bernier G, Brown A, Dalpe G, Mathieu M, De Repentigny Y, Kothary R. Dystonin transcripts are altered and their levels are reduced in the mouse neurological mutant dt24J. Biochem Cell Biol 1995; 73: 605-9.
17. 17. Dowling J, Yang Y, Wollmann R, Reichardt LF, Fuchs E. Developmental expression of BPAG1-n: insights into the spastic ataxia and gross neurologic deqeneration in dystonia musculorum mice. Dev Biol 1997; 187: 131-42.
18. 18. Leung CL, Sun D, Liem RKH. The intermediate filament protein peripherin is the specific interaction partner of mouse BPAG1-n(dystonin) in neurons. J Cell Biol 1999; 144: 435-46.
19. 19. Brown A, Dalpe G, Mathieu M, Kothary. Cloning and characterization of the neural isoforms of human dystonin. Genomics 1995; 29: 777-80.
20. 20. McLean WH, Pulkkinen L, Smith FJ, Rugg EL, Lane EB, Bullrich F, Burgeson RE, Amano S, Hudson DL, Owaribe K, McGrath JA, McMillan JR, Eady RA, Leigh IM, Christiano AM, Uitto J. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev 1996; 10: 1724-35.